Drug application
REZIPAS (AMINOSALICYLIC ACID RESIN COMPLEX)
Drugs@FDA NDA 009052 · BRISTOL MYERS SQUIBB
Key facts
| Drug name | REZIPAS |
|---|---|
| Active ingredients | AMINOSALICYLIC ACID RESIN COMPLEX |
| Application type | NDA |
| Application number | 009052 |
| Company | BRISTOL MYERS SQUIBB |
| Dosage forms | POWDER, ORAL |
| Strength | EQ 500MG BASE/GM |
| Marketing status | Discontinued |
| Reference listed drug | No |
At a glance
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.